文献速递糖尿病

不同糖尿病定义对护理级联指标的影响:88国横断面分析

Comparing Approaches for Deriving Diabetes Care Cascades to Inform Policy: A Cross-sectional Analysis Using National Data From 88 Countries.
PubMed 文献 · Diabetes Care · 2026-01-01

该研究基于2008-2021年88个国家800,348名≥25岁人群的全国代表性横断面数据,比较了基于诊断和基于治疗两种糖尿病定义对护理级联指标的影响。结果显示,两种定义下糖尿病患病率分别为12.9%和11.3%,且诊断和治疗阶段的比例差异中位数分别为11.3%和21.6%,表明定义选择会显著且一致地改变政策结论。

要点

  • 诊断定义较治疗定义提高诊断和控制阶段比例,但降低治疗阶段比例。
  • 两种定义下糖尿病患病率分别为12.9%和11.3%。
  • 达到WHO血糖控制目标的国家比例在诊断定义下为22%,治疗定义下为6%。

核心结论

  • 护理级联估计因糖尿病定义不同而出现大幅且一致的差异,可预测地扭曲政策含义。

研究设计与样本

  • 横断面分析,纳入88个国家2008-2021年800,348名≥25岁具有全国代表性个体。

主要发现

  • 诊断定义下糖尿病患病率为12.9%(95%CI 12.1-13.8),治疗定义下为11.3%(95%CI 10.5-12.1)。
  • 使用诊断定义而非治疗定义,一致提高诊断和控制阶段百分比,但降低治疗阶段百分比。
  • 跨国中位差异:诊断11.3%(IQR 5.1-24.7),治疗21.6%(IQR 14.5-37.8),控制16.4%(IQR 7.8-26.8)。
  • WHO 80%血糖控制目标达成国家比例:诊断定义22%,治疗定义6%。

关键数值与推荐

  • 糖尿病定义:基于诊断(生物标志物升高或自报诊断)vs 基于治疗(生物标志物升高或自报治疗)。
  • 生物标志物升高标准:HbA1c ≥6.5%;空腹血糖 ≥7.0 mmol/L;或随机血糖 ≥11.1 mmol/L。
  • 护理级联指标:诊断比例、治疗比例、血糖控制达标比例。
  • 基准:WHO糖尿病目标(80%血糖控制率)。

临床怎么用

  • 解读和比较各国糖尿病护理级联时需明确糖尿病定义,避免因定义差异导致政策误判。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Care cascade indicators are widely used to monitor national diabetes control efforts. However, diabetes definitions used to derive care cascades vary across studies, which may markedly affect results and subsequent policy decisions. Here, we examine the magnitude of resultant differences between approaches. RESEARCH DESIGN AND METHODS: We analyzed nationally representative, cross-sectional data of 800,348 individuals aged ≥25 years from 88 countries in 2008-2021. We used two different diabetes definitions: elevated biomarkers (glycated hemoglobin [HbA1c] ≥6.5%; fasting plasma glucose ≥7.0 mmol/L; or random plasma glucose ≥11.1 mmol/L) or self-reported diagnosis ("diagnosis-based definition") versus elevated biomarkers or self-reported treatment ("treatment-based definition"). Care cascade estimates included 1) proportions of individuals with diabetes who were diagnosed, and proportions of individuals with diagnosed diabetes who 2) received treatment and 3) attained glycemic control. We benchmarked results against World Health Organization (WHO) diabetes targets. RESULTS: Diabetes prevalence was 12.9% (95% CI 12.1-13.8) applying the diagnosis-based definition and 11.3% (95% CI 10.5-12.1) with the treatment-based definition. Using the diagnosis-based rather than treatment-based diabetes definition to derive care cascades consistently increased the percentages of those who attain diagnosis and control stages but decreased percentages of those receiving treatment. Across countries, median differences between approaches were 11.3% (interquartile range [IQR] 5.1-24.7) for diabetes diagnosis, 21.6% (IQR 14.5-37.8) for treatment, and 16.4% (IQR 7.8-26.8) for control. The WHO 80% glycemic control target was met by 22% versus 6% of countries when using the diagnosis-based versus treatment-based definition, respectively. CONCLUSIONS: Care cascade estimates diverged substantially and consistently across diabetes definitions, skewing policy implications in predictable ways. Harmonizing diabetes performance metrics may improve decision-making and facilitate cross-country comparisons.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Teufel F, Theilmann M, Marcus ME, et al. Comparing Approaches for Deriving Diabetes Care Cascades to Inform Policy: A Cross-sectional Analysis Using National Data From 88 Countries. Diabetes Care. 2026. PMID: 42160589. doi:10.2337/dc26-0267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。